Octavio Marquez - 31 Dec 2023 Form 5 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
President and CEO, Director
Signature
/s/ Elizabeth C. Radigan, Attorney-in-fact for Octavio Marquez
Issuer symbol
DBD
Transactions as of
31 Dec 2023
Net transactions value
+$1,170
Form type
5
Filing time
01 Feb 2024, 12:06:50 UTC
Previous filing
14 Nov 2023
Next filing
23 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Stock Small acquisition under Rule 16a-6 $195 +10 +0.48% $19.52 2,110 19 Sep 2023 Direct F1
transaction DBD Common Stock Small acquisition under Rule 16a-6 $91.95 +5 +0.24% $18.39 2,115 04 Oct 2023 Direct F1
transaction DBD Common Stock Small acquisition under Rule 16a-6 $186 +10 +0.47% $18.59 2,125 16 Oct 2023 Direct F1
transaction DBD Common Stock Small acquisition under Rule 16a-6 $21.35 +1 +0.05% $21.35 2,126 10 Nov 2023 Direct F1
transaction DBD Common Stock Small acquisition under Rule 16a-6 $387 +14 +0.66% $27.67 2,140 18 Dec 2023 Direct F1
transaction DBD Common Stock Small acquisition under Rule 16a-6 $288 +10 +0.47% $28.84 2,150 29 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person acquired these shares of common stock under a broker administered dividend reinvestment plan that were considered a "small acquisition" within the meaning of Rule 16a-6 under the Securities Exchange Act of 1934.